IP Library Assignment 046781/0234
Patent Assignment
Reel/Frame 046781/0234

Assignment of Assignor's Interest

Recorded: 2018-09-04 Pages: 3
Assignor
XIONG, XIAOFENG
Executed: 2018-08-31
Assignee
EIGER BIOPHARMACEUTICALS, INC.
2155 PARK BOULEVARD, PALO ALTO, CALIFORNIA, 94306
Covered Property (1)
Treatment of Hyperinsulinemic Hypoglycemia with Exendin-4 Derivatives
Application: 16/081,578 →
Publication: US 2019/0060413
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest Jun 10, 2022
From: EIGER BIOPHARMACEUTICALS, INC.; EB PHARMA, LLC; EBPI MERGER, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 060156/0901 →
Assignment of Assignor's Interest Aug 14, 2024
From: EIGER BIOPHARMACEUTICALS, INC.
To: AMYLYX PHARMACEUTICALS, INC.
Reel/Frame 068284/0396 →
Assignment of Assignor's Interest Sep 24, 2024
From: EIGER BIOPHARMACEUTICALS, INC.
To: AMYLYX PHARMACEUTICALS, INC.
Reel/Frame 068683/0015 →